glp 1 agonists moa Frontiers Mechanism of Action of GLP-1

I.AnyoguD

Precursors of GSH or GPX biosynthesis, various small molecule activators related to the GSH system and some novel therapeutic approaches, such as exosomes and gene therapy, can boost the activity of the GSH system and reduce cardiac damage and ferroptosis

As such, people have been finding ways to get their hands on these peptides and using them, sometimes with a lack of rigorous human data and trials to prove their safety

Moreover, as there are numerous reports of off-target effects associated with 3PO, further studies are needed to determine the safety and feasibility of targeting PFKFB3 in the context of tumor vascularization (133, 194196)